Healthcare & Life Sciences
TAG Therapeutics
Austriawww.tag-therapeutics.com/
TAG Therapeutics is a Healthcare & Life Sciences startup based in Austria, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About TAG Therapeutics
TAG Therapeutics is a company headquartered in Austria. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
TAG Therapeutics develops TELOBLOCK, an antisense nucleotide therapy that selectively inhibits the DNA damage response at short or damaged telomeres to prevent cellular senescence, with demonstrated efficacy in preclinical models of telomere biology disorders such as pulmonary fibrosis and bone marrow failure.
Explore TAG Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.